Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein
暂无分享,去创建一个
A. von Eckardstein | L. Rohrer | M. Stoffel | J. Nofer | J. Parks | C. Christoffersen | M. Simoni | S. Velagapudi | Dongdong Wang | F. Potì | A. Hülsmeier | A. Lukasz | D. Perisa | Renate Feuerborn | G. Panteloglou | A. Potapenko | M. Yalçınkaya | B. Hesse | Mingxia Liu | M. Yalcinkaya | Srividya Velagapudi
[1] A. von Eckardstein,et al. The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions , 2021, Cells.
[2] A. von Eckardstein,et al. Transendothelial transport of lipoproteins. , 2020, Atherosclerosis.
[3] A. von Eckardstein,et al. Sphingosine-1-phosphate receptors 1 and 3 regulate the expression of scavenger receptor B1 in human aortic endothelial cells , 2020, bioRxiv.
[4] J. Beckman,et al. Sex as a Biological Variable in Atherosclerosis , 2020, Circulation research.
[5] T. Hornemann,et al. Structure-function relationships of HDL in diabetes and coronary heart disease. , 2019, JCI insight.
[6] T. Hla,et al. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.
[7] M. Lauritzen,et al. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis , 2019, bioRxiv.
[8] J. C. Wolters,et al. The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. , 2019, JCI insight.
[9] T. Hla,et al. Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells. , 2019, Biochimica et biophysica acta. General subjects.
[10] T. Lüscher,et al. Mouse Models for Atherosclerosis Research—Which Is My Line? , 2019, Front. Cardiovasc. Med..
[11] E. Fisher,et al. SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis , 2019, Nature.
[12] S. Swendeman,et al. Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury , 2018, Arthritis & rheumatology.
[13] R. Proia,et al. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R−/−) Mice , 2018, Thrombosis and Haemostasis.
[14] C. Christoffersen,et al. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes , 2017, Scientific Reports.
[15] A. von Eckardstein,et al. VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[16] A. von Eckardstein,et al. HDL cholesterol: reappraisal of its clinical relevance , 2017, Clinical Research in Cardiology.
[17] H. Schunkert,et al. Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis. , 2017, Cell metabolism.
[18] S. Swendeman,et al. Impaired endothelial barrier function in apolipoprotein M‐deficient mice is dependent on sphingosine‐1‐phosphate receptor 1 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] A. von Eckardstein,et al. Itinerary of high density lipoproteins in endothelial cells. , 2016, Biochimica et biophysica acta.
[20] M. Cybulsky,et al. A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis. , 2015, Cardiovascular research.
[21] R. Proia,et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation , 2015, Science Signaling.
[22] S. Spiegel,et al. Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles* , 2015, The Journal of Biological Chemistry.
[23] J. Poleszczuk,et al. Can the Three Pore Model Correctly Describe Peritoneal Transport of Protein? , 2014, ASAIO journal.
[24] T. Hornemann,et al. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate , 2014, Journal of Lipid Research.
[25] S. Spiegel,et al. Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein* , 2013, The Journal of Biological Chemistry.
[26] A. von Eckardstein,et al. Interleukin 6 Stimulates Endothelial Binding and Transport of High-Density Lipoprotein Through Induction of Endothelial Lipase , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[27] C. Weber,et al. KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R−/− Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[28] Kim Pin Yeo,et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. , 2013, Cell metabolism.
[29] C. Weber,et al. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice. , 2012, Vascular pharmacology.
[30] T. Hornemann,et al. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. , 2011, Atherosclerosis.
[31] B. Dahlbäck,et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.
[32] Amanda L. Brown,et al. Apolipoprotein M expression increases the size of nascent preβ HDL formed by ATP binding cassette transporter A1 , 2010, Journal of Lipid Research.
[33] A. von Eckardstein,et al. High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1 , 2009, Circulation research.
[34] Jackelyn A. Alva,et al. VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endothelium , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[35] A. von Eckardstein,et al. ATP-Binding Cassette Transporter A1 Modulates Apolipoprotein A-I Transcytosis Through Aortic Endothelial Cells , 2006, Circulation research.
[36] A. von Eckardstein,et al. Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. , 2006, Biochimica et biophysica acta.
[37] M. N. Poy,et al. Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis , 2005, Nature Medicine.
[38] T. Michel,et al. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Wieringa,et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. , 1994, Atherosclerosis.
[40] N. Maeda,et al. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. , 1994, The Journal of clinical investigation.
[41] B. Dahlbäck,et al. High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1 , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[42] A. von Eckardstein,et al. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. , 2013, Circulation journal : official journal of the Japanese Circulation Society.